Search research articles
Contact Us
Filters
Showing results (1-10 of 119) with videos related to
Page
of 12
Sort By:
Journal of Managed Care Pharmacy : JMCP
|
November 14, 2003
Limitations of fentanyl/oxycodone database analysis
Gerry Oster
European Journal of Pain (London, England)
|
May 6, 2008
Summary measures of number needed to treat: how much clinical guidance do they provide in neuropathic pain?
John Edelsberg, Gerry Oster
Archives of Internal Medicine
|
December 10, 2003
Clinical relevance of bleeding index
Gerry Oster, Montserrat Vera
The American Journal of Managed Care
|
November 4, 2014
Is all "skin in the game" fair game? The problem with "non-preferred" generics
Gerry Oster, A Mark Fendrick
Drugs in Context
|
September 1, 2020
Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States
Arpita Nag, Rebecca Bornheimer, Gerry Oster
Clinical Therapeutics
|
December 3, 2013
Economic burden of adverse events in patients with metastatic renal cell carcinoma
May Hagiwara, Rohit Borker, Gerry Oster
The Journal of Infectious Diseases
|
May 31, 2022
Cost-Effectiveness of Adult Universal Hepatitis B Vaccination
Gerry Oster, Rebecca Bornheimer, Kevin Ottino
Diabetes Care
|
September 28, 2002
Response to Lamotte et Al. "A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients."
John Edelsberg, Derek Weycker, Gerry Oster
The Journal of Rheumatology
|
November 18, 2011
Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis
Kaleb Michaud, Montserrat Vera-Llonch, Gerry Oster
Journal of Medical Economics
|
September 6, 2013
Economic burden of selected adverse events in patients aged ≥65 years with metastatic renal cell carcinoma
May Hagiwara, Michelle D Hackshaw, Gerry Oster
Page
of 12
Search research articles
Search
Showing results (1-10 of 119) with videos related to
Sort By:
Page
of 12
Journal of Managed Care Pharmacy : JMCP
|
November 14, 2003
Limitations of fentanyl/oxycodone database analysis
Gerry Oster
European Journal of Pain (London, England)
|
May 6, 2008
Summary measures of number needed to treat: how much clinical guidance do they provide in neuropathic pain?
John Edelsberg, Gerry Oster
Archives of Internal Medicine
|
December 10, 2003
Clinical relevance of bleeding index
Gerry Oster, Montserrat Vera
The American Journal of Managed Care
|
November 4, 2014
Is all "skin in the game" fair game? The problem with "non-preferred" generics
Gerry Oster, A Mark Fendrick
Drugs in Context
|
September 1, 2020
Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States
Arpita Nag, Rebecca Bornheimer, Gerry Oster
Clinical Therapeutics
|
December 3, 2013
Economic burden of adverse events in patients with metastatic renal cell carcinoma
May Hagiwara, Rohit Borker, Gerry Oster
The Journal of Infectious Diseases
|
May 31, 2022
Cost-Effectiveness of Adult Universal Hepatitis B Vaccination
Gerry Oster, Rebecca Bornheimer, Kevin Ottino
Diabetes Care
|
September 28, 2002
Response to Lamotte et Al. "A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients."
John Edelsberg, Derek Weycker, Gerry Oster
The Journal of Rheumatology
|
November 18, 2011
Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis
Kaleb Michaud, Montserrat Vera-Llonch, Gerry Oster
Journal of Medical Economics
|
September 6, 2013
Economic burden of selected adverse events in patients aged ≥65 years with metastatic renal cell carcinoma
May Hagiwara, Michelle D Hackshaw, Gerry Oster
Page
of 12